Scarica l'app Stockscreener
4.10
9.63%
0.36
Dopo l'orario di chiusura:
4.09
-0.010
-0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SAVA Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$3.74
Aprire:
$3.86
Volume 24 ore:
2.08M
Relative Volume:
0.96
Capitalizzazione di mercato:
$198.06M
Reddito:
-
Utile/perdita netta:
$-97.22M
Rapporto P/E:
-2.971
EPS:
-1.38
Flusso di cassa netto:
$-82.44M
1 W Prestazione:
+14.85%
1M Prestazione:
+94.31%
6M Prestazione:
+222.83%
1 anno Prestazione:
-84.11%
Intervallo 1D:
$3.82
$4.10
Intervallo di 1 settimana:
$3.39
$4.28
Portata 52W:
$1.15
$33.98
Cassava Sciences Inc Stock (SAVA) Company Profile
Nome
Cassava Sciences Inc
Settore
Industria
Telefono
512-501-2444
Indirizzo
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Confronta SAVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
4.10 | 180.67M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-27 | Iniziato | B. Riley Securities | Buy |
| 2021-02-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-09-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | Downgrade | Maxim Group | Buy → Hold |
| 2020-01-10 | Reiterato | Maxim Group | Buy |
Mostra tutto
Cassava Sciences Inc Borsa (SAVA) Ultime notizie
Sentiment analysis tools applied to Cassava Sciences Inc. Equity WarrantDip Buying & Smart Allocation Stock Reports - newser.com
Published on: 2025-10-13 08:27:20 - newser.com
Exit strategy if you’re trapped in Cassava Sciences Inc.Index Update & Community Shared Stock Ideas - newser.com
Is Cassava Sciences Inc. Equity Warrant a candidate for recovery play2025 Major Catalysts & Capital Efficiency Focused Strategies - newser.com
Published on: 2025-10-13 08:03:22 - newser.com
What the charts say about Cassava Sciences Inc. todayPortfolio Value Report & Expert Verified Stock Movement Alerts - newser.com
How risky is Cassava Sciences Inc. stock nowAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com
Will Cassava Sciences Inc. stock outperform Dow Jones indexGDP Growth & Weekly High Conviction Trade Ideas - newser.com
Why Cassava Sciences Inc. stock is favored by pension fundsJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
Can Cassava Sciences Inc. Equity Warrant stock maintain operating marginsQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com
Visual trend scoring systems applied to Cassava Sciences Inc.2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Chart overlay techniques for tracking Cassava Sciences Inc. Equity WarrantWeekly Gains Summary & Verified Technical Signals - newser.com
What analysts say about Cassava Sciences Inc Equity Warrant stockLow Risk Investment Ideas & Free Daily Stock Hotspot Analysis - earlytimes.in
Cassava Sciences Inc. stock outlook for YEARJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Risk vs reward if holding onto Cassava Sciences Inc. Equity WarrantShare Buyback & Verified Entry Point Detection - newser.com
What data driven models say about Cassava Sciences Inc.’s futureQuarterly Earnings Summary & Real-Time Volume Surge Alerts - newser.com
What indicators show strength in Cassava Sciences Inc.Market Performance Summary & Verified Momentum Stock Alerts - newser.com
Understanding Cassava Sciences Inc. Equity Warrant’s price movementJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com
Pattern recognition hints at Cassava Sciences Inc. upsideWeekly Gains Summary & Weekly Watchlist for Consistent Profits - newser.com
Will Cassava Sciences Inc. (PX91) stock beat growth indexes2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
Can Cassava Sciences Inc. Equity Warrant hit a new high this monthQuarterly Portfolio Report & Weekly Chart Analysis and Guides - newser.com
Should you hold or exit Cassava Sciences Inc. Equity Warrant nowJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Is Cassava Sciences Inc. (PX91) stock a buy during volatile marketsJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
How hedge fund analytics apply to Cassava Sciences Inc. Equity Warrant stock2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Chart based exit strategy for Cassava Sciences Inc.Earnings Miss & Real-Time Volume Analysis Alerts - newser.com
Can Cassava Sciences Inc. Equity Warrant recover in the next quarterWeekly Trend Report & Smart Swing Trading Alerts - newser.com
Using RSI to spot recovery in Cassava Sciences Inc. Equity Warrant2025 Price Momentum & Community Verified Trade Alerts - newser.com
Can Cassava Sciences Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
Cassava Sciences Inc. Equity Warrant stock trend outlook and recovery pathInsider Selling & Weekly Top Gainers Trade List - newser.com
LUCID CAPITAL MARKETS Initiates Coverage of Cassava Sciences (SAVA) with Buy Recommendation - Nasdaq
Cassava Sciences (SAVA): Lucid Capital Markets Initiates Coverage with Buy Rating | SAVA Stock News - GuruFocus
Lucid Capital Upgrades Cassava Sciences(SAVA.US) to Buy Rating, Raises Target Price to $8 - 富途牛牛
How to build a dashboard for Cassava Sciences Inc. Equity Warrant stockTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com
Will Cassava Sciences Inc. (PX91) stock benefit from mergers2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Will Cassava Sciences Inc. stock gain from lower inflationGap Up & Weekly Chart Analysis and Trade Guides - newser.com
Is Cassava Sciences Inc. (PX91) stock a safe buy pre earningsMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Can Cassava Sciences Inc. Equity Warrant stock continue upward trendTrade Risk Report & Weekly Sector Rotation Insights - newser.com
Cassava Sciences Inc. Equity Warrant stock daily chart insightsRecession Risk & Real-Time Market Trend Scan - newser.com
Is Cassava Sciences Inc. Equity Warrant meeting your algorithmic filter criteria2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Cassava Sciences Inc. Equity Warrant stock retracement – recovery analysisExit Point & Low Drawdown Trading Strategies - newser.com
FRST Stock Analysis and ForecastFederal Reserve Announcements & Free Long-Term Investment Planning - earlytimes.in
Is Cassava Sciences Inc a good long term investmentMACD Trading Signals & Investment Timing Techniques - earlytimes.in
Best data tools to analyze Cassava Sciences Inc. Equity Warrant stock2025 Trading Recap & Growth Oriented Trade Recommendations - newser.com
Cassava Sciences Inc Azioni (SAVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):